MRC1 and colorectal carcinoma: Studies have suggested that changes in the target binding sites of certain miRNAs in the MMR gene could potentially predict CRC risk and prognosis, and specific miRNAs may play a role in regulating the core heterologous proteins of the MMR [51–54].